TRCT
NARI

Tower Research Capital (TRC)’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Tower Research Capital (TRC)’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,192
Closed -$214K – 6008
2024
Q4 		$214K Buy
4,192
+793
+23% +$39K ﹤0.01% 1670
2024
Q3 		$140K Sell
3,399
-3,430
-50% -$165K ﹤0.01% 1954
2024
Q2 		$329K Sell
6,829
-11,668
-63% -$517K 0.01% 1677
2024
Q1 		$887K Buy
18,497
+12,648
+216% +$676K 0.02% 566
2023
Q4 		$380K Buy
5,849
+2,538
+77% +$153K ﹤0.01% 1596
2023
Q3 		$217K Sell
3,311
-4,892
-60% -$308K 0.01% 1378
2023
Q2 		$477K Buy
8,203
+5,999
+272% +$378K 0.02% 1020
2023
Q1 		$136K Buy
2,204
+1,050
+91% +$63K ﹤0.01% 1602
2022
Q4 		$74K Sell
1,154
-7,926
-87% -$575K ﹤0.01% 2067
2022
Q3 		$660K Buy
9,080
+1,834
+25% +$137K 0.01% 928
2022
Q2 		$493K Buy
7,246
+5,876
+429% +$422K 0.01% 1144
2022
Q1 		$124K Sell
1,370
-368
-21% -$30.1K ﹤0.01% 2056
2021
Q4 		$158K Buy
1,738
+711
+69% +$60.9K ﹤0.01% 1939
2021
Q3 		$83K Buy
1,027
+342
+50% +$28.7K ﹤0.01% 2554
2021
Q2 		$64K Sell
685
-690
-50% -$66.9K ﹤0.01% 2815
2021
Q1 		$147K Sell
1,375
-1,524
-53% -$158K ﹤0.01% 2270
2020
Q4 		$253K Buy
2,899
+1,734
+149% +$122K 0.01% 1534
2020
Q3 		$80K Buy
+1,165
New +$74.9K ﹤0.01% 3308

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Tower Research Capital (TRC)'s NARI Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 4,192 shares — an estimated $214K sold.

Tower Research Capital (TRC) first reported a position in NARI in Q3 2020 and held it in 18 quarters. The position peaked at $887K in Q1 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,192 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $214K.
  • Tower Research Capital (TRC) first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • Tower Research Capital (TRC)'s Inari Medical, Inc. Common Stock position peaked at $887K in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.